Relay Therapeutics Inc Revenue per Employee (RLAY), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Relay Therapeutics Inc   (NASDAQ: RLAY)
 

Relay Therapeutics Inc 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


Relay Therapeutics Inc 's Revenue per employee fell on a trailing twelve month basis to $ 53,901, but the productivity of Relay Therapeutics Inc 's employees remained above the company average.
Within the Healthcare sector Relay Therapeutics Inc achieved the highest revenue per employee. While revenue per employee remained unchanged compared to the previous quarter at no. .Relay Therapeutics Inc has 192 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

RLAY Revenue per Employee (Sep 30 2026)
III. Quarter		 (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter
Y / Y Revenue Change - -48.3 % -60.93 % - -
Sales per Employee (TTM) $ 53,901 53,901 55,604 79,974 43,521
RLAY's Total Ranking # # # # #
Seq. Revenue Change - -88.33 % -57.14 % - -

RLAY Company Profile >> Back to RLAY Efficiency Comparisons >> Compare RLAY Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall Market #

Revenue per Employee Statistics
High Average Low
$ 183,995 $ 51,782 $ 4,906
(Mar 31 2024)   (Jun 30 2023)



Financial Statements
Relay Therapeutics Inc 's Revenue MRQ $ 0 Millions Visit RLAY's Income Statement
Relay Therapeutics Inc 's Revenues TTM $ 10 Millions Visit RLAY's aggregate revenue growth
What are RLAY's Sales? Visit RLAY's Sales by Segment




Other Ratios
Relay Therapeutics Inc 's Income per Employee
Employees in Biotechnology & Pharmaceuticals
Biotechnology & Pharmaceuticals Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
RLAY's Revenue per Employee versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for RLAY's Competitors
Revenue per Employee for RLAY's Suppliers
Revenue per Employee for RLAY's Customers

You may also want to know
RLAY's Sales Growth Rates RLAY's Pe Price to earnings ratio RLAY's Receivables Turnover Ratio RLAY's Stock Quote
RLAY's Net Income Growth Rates RLAY's Ps Price to Sales ratio RLAY's Sales per Employee RLAY's Asset Turnover Ratio
RLAY's Net Margin RLAY's Pb Price to Book ratio RLAY's Financial Strength Ratios RLAY's Dividend Payout Ratio
Date modified: 2026-11-05T09:44:17+00:00




Companies with similar Revenue per Employee for 12 months ending Sep 30 2026, within Healthcare Sector Revenue per Employee Revenue 12 months ending Sep 30 2026Number of Employees Sep 30 2026
Aclaris Therapeutics Inc   87,684.93 $ 6.401  Million 73 
Biomerica Inc   86,760.00 $ 4.338  Million 50 
Teleflex Incorporated  82,817.74 $ 1,283.675  Million 15,500 
Lenz Therapeutics Inc   81,309.21 $ 12.359  Million 152 
Healthcare Services Group Inc   52,218.33 $ 1,879.860  Million 36,000 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.